FASN and cancer: Consequently, the regulators of cancer cell metabolism have emerged as attractive therapeutic targets and primarily include genes that are significantly altered between normal and cancer cells, such as glucose transporters (GLUT1, GLUT4), hexokinase (HK1), pyruvate kinase (PKM2) and fatty acid synthase (FASN)49, 50.